Dominican Republic
Tuberculosis profile
| High HIV burden |
Population  2012 10 million
Estimates of TB burden * 2012 Number (thousands) Rate
(per 100 000 population)
Mortality (excludes HIV+TB) 0.46 (0.38–0.55) 4.4 (3.7–5.3)
Mortality (HIV+TB only) 0.13 (0.11–0.18) 1.3 (1.1–1.8)
Prevalence  (includes HIV+TB) 10 (4.9–17) 98 (48–165)
Incidence  (includes HIV+TB) 6.4 (5.3–7.6) 62 (51–74)
Incidence (HIV+TB only) 0.54 (0.44–0.64) 5.2 (4.3–6.3)
Case detection, all forms (%) 67 (56–81)    
TB case notifications 2012        
New cases   (%) Retreatment cases (%)
Smear-positive 2 483 (64) Relapse 374 (68)
Smear-negative 681 (18) Treatment after failure 0 (0)
Smear-unknown / not done 136 (3) Treatment after default 178 (32)
Extrapulmonary 544 (14) Other 0 (0)
Other 44 (1)      
Total new 3 888   Total retreatment 552  
           
Other (history unknown) 0        
Total new and relapse 4 262   Total cases notified 4 440  
New cases Smear-positive Smear-negative/ unknown/
not done
Extrapulmonary
M:F ratio 1.7    
Age < 15 41 67 43
Laboratories 2012
Smear (per 100 000 population) 2.0
Culture (per 5 million population) 5.8
Drug susceptibility testing (per 5 million population) 1.0
Is second-line drug susceptibility testing available? Yes, in country
Treatment success rate 2011 (%)        
New smear-positive and/or culture-positive 83   Is rifampicin used
throughout treatment for
new patients?
Yes
New smear-negative/extrapulmonary    
Retreatment 61  
TB/HIV 2012 Number (%)
TB patients with known HIV status 2 721 (61)
HIV-positive TB patients 557 (20)
HIV-positive TB patients on co-trimoxazole preventive therapy (CPT) 386 (69)
HIV-positive TB patients on antiretroviral therapy (ART) 268 (48)
HIV-positive people screened for TB    
HIV-positive people provided with IPT    
Estimates of MDR-TB burden 2012*   New   Retreatment
% of TB cases with MDR-TB 6.6 (4.1–10) 20 (13–28)
MDR-TB cases among notified pulmonary
TB cases
220 (140–330) 110 (71–150)
Reported cases of MDR-TB 2012 New Retreatment Total
Cases tested for MDR-TB 79 (3%) 193 (35%) 398
Laboratory-confirmed MDR-TB cases 12 80 92
Patients started on MDR-TB treatment     109
Financing TB control 2013
National TB programme budget (US$ millions) 15
% Funded domestically 50%
% Funded internationally 25%
% Unfunded 25%
***
(Rate per 100 000 population per year)
Mortality graph
___ Mortality  (excludes HIV+TB)

(Rate per 100 000 population)
Prevalence graph
___ Prevalence

(Rate per 100 000 population per year)
Incidence graph
__ Notifications Incidence
___
___ Incidence (HIV+TB only)

Treatment success rate (%)
tx success graph
__ New smear-positive and/or culture-positive
__ New smear-negative/extrapulmonary __
Retreatment

(Number of patients)
CPT ART graph
__ HIV-positive TB patients
__ on CPT __ on ART

Total budget (US$ millions)
Budget funding Graph
__ Funded domestically __ Funded internationally
__ Unfunded
 
 Data are as reported to WHO. Estimates of TB and MDR-TB burden are produced by WHO in consultation with countries.
 * Ranges represent uncertainty intervals Generated: 2014-04-24 Data: www.who.int/tb/data